These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3519061)

  • 1. [Randomized clinical study of the efficacy of buflomedil in the prevention of recurrence of cerebral ischemia in comparison with anti-platelet aggregation agents].
    De Martiis M; Parenzi A; Barlattani A; De Martiis A
    Clin Ter; 1986 Mar; 116(5):367-71. PubMed ID: 3519061
    [No Abstract]   [Full Text] [Related]  

  • 2. [Secondary prevention of ischemic insult and transient cerebral ischemia. Is ASS alone enough?].
    Diener HC
    MMW Fortschr Med; 2003 May; 145 Suppl 2():111. PubMed ID: 14579505
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of recurrences of cerebral ischemic vascular accidents by platelet antiaggregants. Results of a 3-year controlled therapeutic trial].
    Guiraud-Chaumeil B; Rascol A; David J; Boneu B; Clanet M; Bierme R
    Rev Neurol (Paris); 1982; 138(5):367-85. PubMed ID: 6815756
    [No Abstract]   [Full Text] [Related]  

  • 4. [anti-platelet therapy or anti-coagulants as prevention in transient ischemic attacks and reversible ischemic stroke].
    Brechter C; Bäcklund H; Krook H; Müller R; Nitelius E; Olsson JE; Olsson O; Thornberg A
    Lakartidningen; 1980 Dec; 77(52):4947-56. PubMed ID: 7010029
    [No Abstract]   [Full Text] [Related]  

  • 5. [Guidelines recommend aspirin/dipyridamole retard in high recurrence risk. Well protected from the second stroke].
    Schwab S
    MMW Fortschr Med; 2009 Jul; 151(30-33):60-1. PubMed ID: 19722467
    [No Abstract]   [Full Text] [Related]  

  • 6. [Role of antiplatelet agents in the prevention of cerebral ischemic accidents].
    Bousser MG
    J Mal Vasc; 1983; 8(1):17-22. PubMed ID: 6341494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events.
    Gengo FM; Rainka M; Robson M; Gengo MF; Forrest A; Hourihane M; Bates V
    J Clin Pharmacol; 2008 Mar; 48(3):335-43. PubMed ID: 18223144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of dipyridamole in patients with recent stroke or TIA.
    Bernstein RA
    Am Fam Physician; 2005 Aug; 72(3):382, 384; author reply 384. PubMed ID: 16100852
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevention of vascular complications after cerebral ischemia of arterial origin. European Stroke and Australian Stroke Prevention in Reversible Ischemia Trial (ESPRIT): moderated coagulation, aspirin-dipyridamole combination or aspirin alone?].
    De Schryver EL; Gorter JW; Algra A; van Gijn J
    Rev Med Interne; 1999 May; 20(5):397-9. PubMed ID: 10365408
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The combination of acetylsalicylic acid and dipyridamole is more effective in secondary prevention following transient ischaemic attack or cerebral infarction: the debate is closed].
    Schrama E; Eusman JP
    Ned Tijdschr Geneeskd; 2006 Dec; 150(48):2672; author reply 2672-3. PubMed ID: 17205946
    [No Abstract]   [Full Text] [Related]  

  • 12. ["A.I.C.L.A." controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Part I: Protocol (author's transl)].
    Bousser MG; Eschwege E; Haguenau M; Lefauconnier JM; Touboul D; Touboul PJ
    Rev Neurol (Paris); 1981; 137(5):333-41. PubMed ID: 7027408
    [No Abstract]   [Full Text] [Related]  

  • 13. [The combination of acetylsalicylic acid and dipyridamole is more effective in secondary prevention following transient ischaemic attack or cerebral infarction: the debate is closed].
    Offerhaus L
    Ned Tijdschr Geneeskd; 2006 Dec; 150(48):2673; author reply 2673-4. PubMed ID: 17205947
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
    Biller J
    J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
    Kirshner HS
    Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [After stroke or TIA. Double protection by second platelet inhibitor].
    MMW Fortschr Med; 2003 Dec; 145(50):57. PubMed ID: 14963978
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevention of recurrence of cerebrovascular thromboses. A randomized comparative study of acetylsalicylic acid and sodium pentosan polysulfate].
    Vinazzer H
    Fortschr Med; 1987 Feb; 105(5):79-85. PubMed ID: 2435643
    [No Abstract]   [Full Text] [Related]  

  • 18. Network meta-analysis: simultaneous meta-analysis of common antiplatelet regimens after transient ischaemic attack or stroke.
    Thijs V; Lemmens R; Fieuws S
    Eur Heart J; 2008 May; 29(9):1086-92. PubMed ID: 18349026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view.
    Gebel JM
    J Am Coll Cardiol; 2005 Sep; 46(5):752-5. PubMed ID: 16139120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ticlopidine-pentoxifylline combination in the treatment of atherosclerosis and the prevention of cerebrovascular accidents.
    Apollonio A; Castignani P; Magrini L; Angeletti R
    J Int Med Res; 1989; 17(1):28-35. PubMed ID: 2651175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.